Hidradenitis suppurativa - Hydradenitis Suppurativa
☆ Muzotsatira za 2022 Stiftung Warentest zochokera ku Germany, kukhutitsidwa kwa ogula ndi ModelDerm kunali kotsika pang'ono kusiyana ndi kuyankhulana kwa telemedicine komwe kulipiridwa.
Hydradenitis Suppurativa (Hidradenitis suppurativa) (siteji I) mukhwapa. Iyi ndi nkhani yofatsa kwambiri ya Hydradenitis Suppurativa (Hidradenitis suppurativa).
References
Hidradenitis suppurativa ndi matenda a khungu omwe sakhalitsa, omwe amabwereranso, ndipo amatha kusokoneza kwambiri moyo wanu. Zimayamba chifukwa cha kutupa kwa tsitsi, ndipo nthawi zambiri zimayambitsa matenda a bakiteriya. Madokotala nthawi zambiri amazindikira matendawa poyang'ana mitundu ya zilonda zomwe muli nazo (monga timinofu, zithupsa, kapena timapepala ta m'mphuno) , komwe zimakhala (nthawi zambiri zimakhala zomangira pakhungu) , komanso momwe zimabwerera komanso nthawi yayitali bwanji.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
Mankhwala osakhala a biologic komanso osagwiritsa ntchito njira amagwiritsidwa ntchito kawirikawiri paokha pa matenda ochepetsetsa ndipo amatha kuphatikizidwa ndi biologic therapy ndi opaleshoni ya matenda apakati kapena aakulu. Kafukufuku waposachedwa akupereka umboni wowonjezereka wogwiritsa ntchito ma corticosteroids omwe amabayidwa mwachindunji muzotupa za HS flare-ups ndi zotupa zapamalo. Komanso, pali umboni wosonyeza kuti kugwiritsa ntchito tetracycline kokha kungakhale kothandiza monga kuphatikiza clindamycin ndi rifampicin.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
Mankhwala ambiri amagwiritsidwa ntchito pa hidradenitis suppurativa, kuphatikizapo maantibayotiki, retinoids, antiandrogens, mankhwala oletsa chitetezo cha mthupi, mankhwala oletsa kutupa, ndi radiotherapy kwa zotupa zoyambirira. Mankhwala omwe akulimbikitsidwa kwambiri ndi adalimumab ndi laser therapy. Kupanga maopaleshoni, mwina kung'amba pang'ono kapena kumeta kwam'deralo ndi kumezanitsa khungu, ndiye njira yabwino kwambiri paziwopsezo zazikulu zomwe sizimayankha bwino pamankhwala ena.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Zomwe zimayambitsa nthawi zambiri sizidziwika, koma amakhulupirira kuti zimaphatikizapo kuphatikiza kwa majini ndi chilengedwe. Pafupifupi gawo limodzi mwa magawo atatu a anthu omwe ali ndi matendawa amakhala ndi achibale omwe akhudzidwa. Zifukwa zina zowopsa ndi kunenepa kwambiri ndi kusuta. Matendawa samayambitsidwa ndi matenda, ukhondo.
Palibe mankhwala omwe amadziwika. Kudula zilonda kuti zilole kukhetsa sikubweretsa phindu lalikulu. Ngakhale kuti maantibayotiki amagwiritsidwa ntchito kawirikawiri, umboni wa ntchito yawo ndi wochepa. Mankhwala a immunosuppressive angathenso kuyesedwa. Kwa omwe ali ndi matenda oopsa kwambiri, chithandizo cha laser kapena opaleshoni kuchotsa khungu lomwe lakhudzidwa lingakhale lotheka. Nthaŵi zambiri, zilonda zapakhungu zimatha kukhala khansa yapakhungu.
Ngati milandu yochepa ya hydradenitis suppurativa (hidradenitis suppurativa) ikuphatikizidwa, ndiye kuti kuyerekezera kwafupipafupi kwake kumachokera ku 1-4% ya anthu. Azimayi ali ndi mwayi wopezeka nawo katatu kuposa amuna. Kuyamba kumachitika nthawi zambiri akakula.